FLASH SPRING SALE: 50% Off Premium Subscription >> FLASH SPRING SALE: 50% Off Premium >>
$12.18
+0.83 (+7.31%)
At Close: May 01, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $10.11 $12.52 Wednesday, 1st May 2024 KALV stock ended at $12.18. This is 7.31% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 10.31% from a day low at $11.35 to a day high of $12.52.
90 days $10.11 $16.88
52 weeks $7.21 $16.88

Historical KalVista Pharmaceuticals Inc prices

Date Open High Low Close Volume
Jan 12, 2024 $13.25 $13.35 $12.75 $12.96 465 136
Jan 11, 2024 $12.74 $13.14 $12.42 $13.12 296 316
Jan 10, 2024 $12.61 $13.13 $12.38 $12.71 285 958
Jan 09, 2024 $12.88 $13.00 $12.33 $12.77 372 976
Jan 08, 2024 $11.71 $13.05 $11.58 $13.00 443 996
Jan 05, 2024 $11.52 $11.71 $11.18 $11.37 318 579
Jan 04, 2024 $12.13 $12.22 $11.60 $11.73 259 224
Jan 03, 2024 $12.14 $12.56 $11.93 $12.13 229 116
Jan 02, 2024 $12.53 $12.99 $11.98 $12.15 343 860
Dec 29, 2023 $12.14 $12.60 $11.93 $12.25 227 781
Dec 28, 2023 $11.94 $12.75 $11.70 $12.08 1 213 358
Dec 27, 2023 $11.99 $12.10 $11.57 $12.04 343 795
Dec 26, 2023 $11.74 $11.93 $11.32 $11.83 332 663
Dec 22, 2023 $11.42 $11.80 $11.27 $11.68 307 804
Dec 21, 2023 $11.19 $11.40 $10.65 $11.27 146 558
Dec 20, 2023 $11.01 $11.58 $10.82 $11.00 292 983
Dec 19, 2023 $10.76 $11.22 $10.43 $11.06 308 974
Dec 18, 2023 $10.52 $10.77 $10.32 $10.65 253 760
Dec 15, 2023 $10.54 $10.93 $10.19 $10.68 1 115 350
Dec 14, 2023 $10.14 $10.78 $9.87 $10.50 460 054
Dec 13, 2023 $9.75 $10.19 $9.31 $9.90 302 077
Dec 12, 2023 $8.88 $9.95 $8.19 $9.76 540 068
Dec 11, 2023 $8.19 $8.85 $7.39 $8.79 618 556
Dec 08, 2023 $8.90 $8.90 $7.92 $8.16 380 288
Dec 07, 2023 $8.92 $9.00 $8.44 $8.97 226 969
Click to get the best stock tips daily for free!

About KalVista Pharmaceuticals Inc

KalVista Pharmaceuticals KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral plasma kallikrein inhibitors. Its products include KVD001, a plasma kallikrein inhibitor that completed ... KALV Profile

Golden Star

Ticker Date Change Price
HRB Apr 29 1.00% $47.23
LYG Apr 29 0.391% $2.56
ORA Apr 29 1.95% $64.48
ETSY Apr 26 3.43% $67.43
DHT Apr 24 0.98% $11.28
LPLA Apr 19 1.10% $262.59
MLI Apr 19 7.29% $52.28
PFLT Apr 18 1.33% $11.25
DOOR Apr 18 0.94% $131.39
OCSL Apr 17 0.360% $19.43
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT